CLIC function in GPCR-mediated Rho/Rac signaling
CLIC 在 GPCR 介导的 Rho/Rac 信号传导中的功能
基本信息
- 批准号:9973544
- 负责人:
- 金额:$ 42.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdrenergic AgentsAgonistAmino AcidsBindingBiological AssayBloodC-terminalCLIC4 geneCaenorhabditis elegansCardiovascular systemCell membraneCellsChimera organismChloride ChannelsChloridesClinical TrialsComplexDataDefectDevelopmentDiseaseEmbryoEndothelial CellsEndotheliumEngineeringFDA approvedFamilyFibroblastsG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP-Binding Protein alpha Subunits, GsGenesGeneticGlutathione S-TransferaseGuanosine Triphosphate PhosphohydrolasesHeterotrimeric GTP-Binding ProteinsHumanHuman BiologyIon ChannelKnowledgeLabelLinkLymphatic Endothelial CellsMammalian CellMeasuresMediatingMembraneModelingMolecularMusMutant Strains MiceMutationN-terminalNucleic Acid Regulatory SequencesOrthologous GenePathway interactionsPericytesPharmaceutical PreparationsPhenotypePhysiologicalPhysiologyProtein FamilyProtein Tyrosine KinaseProteinsProteomicsRegulationRoleSH3-Binding MotifSignal PathwaySignal TransductionSpecificitySphingosine-1-Phosphate ReceptorStructureSurveysSystemTestingThrombinTubeVariantWorkangiogenesisbasecell behaviorcell typeclinically significantfunctional restorationin vivomutantmyristoylationnovelprotein complexresponserhorho GTP-Binding Proteinssensorsphingosine 1-phosphatetool
项目摘要
G-protein-coupled receptor (GPCR)-mediated regulation of the GTPases Rho and Rac is a conserved signaling
module required for vital cell behaviors. However, the mechanisms that connect GPCRs, and their heterotrimeric
G-protein (Gα/β/γ) partners, to Rho/Rac are not fully delineated. Our studies in C. elegans and human endothelial
cells have revealed a new conserved player required for Rho/Rac signaling: the Chloride Intracellular Channel
(CLIC) family of proteins. Our data shows that CLICs are required in two important endothelial GPCR pathways
(S1P/S1P Receptor and thrombin/PAR) that function through Gα12/13 and Gαi to activate Rho and Rac. This
CLIC function is evolutionarily conserved, because we found that in C. elegans the CLIC ortholog exc-4
genetically interacts with the Gα12 ortholog gpa-12 and with the Rac orthologs ced-10 and mig-2. The molecular
function of CLICs has long remained a mystery. Based on sequence and structural similarities, they have been
proposed to function as chloride channels and/or as glutathione S-transferases (GST). Previous work has shown
that EXC-4 membrane localization is mediated by an N-terminal domain and this localization is critical for function.
We have now found that CLIC membrane localization is also critical for its role in GPCR-mediated Rho/Rac
activation in endothelial cells, and that replacement of the membrane-targeting N-terminus with a myristoylation
signal is sufficient to restore this function. Since the channel and GST activities of CLICs require an intact N-
terminus we have discovered a novel activity for CLICs. We hypothesize that CLICs are membrane-localized
regulators of Rho and Rac that respond to GPCR-Gα signaling. In Aim 1 we will determine how CLICs couple
GPCR-Gα (Gα12/13 and Gαi) signaling to Rho and Rac. We will survey the requirement for CLICs in different cell
and signaling contexts to define key GPCR-Gα combinations that utilize CLICs to regulate of Rho and Rac. We
will use cutting-edge bio-sensors and genetic tools to measure and modulate signaling to determine which step
in the GPCR-Gαβγ-Rho/Rac cascade requires CLICs. Finally, we will test whether CLICs physically interact with
Rho/Rac to modulate signaling. In Aim 2 we will define the determinants by which CLICs regulate Rho/Rac in
human cells and in C. elegans by performing structure-function analyses, focused on the EXC-4/CLIC C-
terminus. Critical domains defined in this Aim will be tested for their ability to interact with Rho/Rac (as defined
in Aim 1). In Aim 3 we will carry out unbiased genetic and proteomic screens in C. elegans to find conserved
players that genetically and physically interact with EXC-4/CLIC to further elucidate how CLICs regulate Rho/Rac
signaling. We will then test whether human orthologs of genes identified in these screens influence Rho/Rac
signaling in mammalian cells. By defining new mechanisms of action for CLICs in GPCR-Gαβγ-Rho/Rac signaling
we will significantly increase our knowledge of how GPCRs influence human biology and uncover new ways of
targeting these pathways.
G蛋白偶联受体(GPCR)介导的GTP酶Rho和Rac的调节是一种保守的信号传导途径,
重要细胞行为所需的模块。然而,连接GPCR及其异源三聚体的机制,
G-蛋白(Gα/β/γ)伴侣与Rho/Rac的关系尚未完全阐明。我们在C.秀丽线虫和人类内皮细胞
细胞揭示了Rho/Rac信号传导所需的一个新的保守参与者:细胞内氯离子通道
(CLIC)蛋白质家族。我们的数据显示CLIC在两个重要的内皮GPCR途径中是必需的
(S1P/S1 P受体和凝血酶/PAR),其通过Gα12/13和Gαi起作用以激活Rho和Rac。这
CLIC功能在进化上是保守的,因为我们发现在C. elegans的CLIC直系同源物exc-4
与Gα12直系同源物gpa-12以及与Rac直系同源物ced-10和mig-2遗传相互作用。分子
CLIC的功能长期以来一直是一个谜。基于序列和结构的相似性,
提出作为氯离子通道和/或谷胱甘肽S-转移酶(GST)起作用。以前的工作表明
EXC-4膜定位是由N-末端结构域介导的,并且这种定位对于功能至关重要。
我们现在发现CLIC膜定位对于其在GPCR介导的Rho/Rac中的作用也是关键的
在内皮细胞中的活化,以及用豆蔻酰化取代膜靶向N-末端
信号足以恢复该功能。由于CLIC的通道和GST活动需要完整的N-
我们发现了CLIC的一种新活性。我们假设CLIC是膜定位的,
响应GPCR-Gα信号传导的Rho和Rac调节子。在目标1中,我们将确定CLIC如何耦合
GPCR-Gα(Gα12/13和Gαi)向Rho和Rac的信号传导。我们将调查不同单元对CLIC的需求
和信号传导上下文来定义利用CLIC来调节Rho和Rac的关键GPCR-Gα组合。我们
将使用尖端的生物传感器和遗传工具来测量和调节信号,以确定哪一步
在GPCR-Gαβγ-Rho/Rac级联中,需要CLIC。最后,我们将测试CLIC是否与
Rho/Rac调节信号传导。在目标2中,我们将定义CLIC调节Rho/Rac的决定因素,
人细胞和C. elegans的结构-功能分析,重点是EXC-4/CLIC C-
终点站将测试本目标中定义的关键域与Rho/Rac(如定义)相互作用的能力
目标1)。在目标3中,我们将在C. elegans发现保守的
基因和物理上与EXC-4/CLIC相互作用的参与者,以进一步阐明CLIC如何调节Rho/Rac
发信号。然后,我们将测试在这些筛选中鉴定的基因的人类直系同源物是否影响Rho/Rac
哺乳动物细胞中的信号传导。通过定义CLIC在GPCR-Gαβγ-Rho/Rac信号传导中的新作用机制,
我们将大大增加我们对GPCR如何影响人类生物学的了解,并发现新的方法,
针对这些路径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jan K. Kitajewski其他文献
Correction to: Notch regulates vascular collagen IV basement membrane through modulation of lysyl hydroxylase 3 trafficking
- DOI:
10.1007/s10456-021-09801-w - 发表时间:
2021-06-08 - 期刊:
- 影响因子:9.200
- 作者:
Stephen J. Gross;Amelia M. Webb;Alek D. Peterlin;Jessica R. Durrant;Rachel J. Judson;Qanber Raza;Jan K. Kitajewski;Erich J. Kushner - 通讯作者:
Erich J. Kushner
Jan K. Kitajewski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jan K. Kitajewski', 18)}}的其他基金
CLIC function in GPCR-mediated Rho/Rac signaling
CLIC 在 GPCR 介导的 Rho/Rac 信号传导中的功能
- 批准号:
10552564 - 财政年份:2020
- 资助金额:
$ 42.63万 - 项目类别:
Vascular Biology, Signaling and Therapeutics training program
血管生物学、信号传导和治疗学培训计划
- 批准号:
10427309 - 财政年份:2019
- 资助金额:
$ 42.63万 - 项目类别:
Vascular Biology, Signaling and Therapeutics training program
血管生物学、信号传导和治疗学培训计划
- 批准号:
10646394 - 财政年份:2019
- 资助金额:
$ 42.63万 - 项目类别:
Vascular Biology, Signaling and Therapeutics training program
血管生物学、信号传导和治疗学培训计划
- 批准号:
9902520 - 财政年份:2019
- 资助金额:
$ 42.63万 - 项目类别:
Vascular Biology, Signaling and Therapeutics training program
血管生物学、信号传导和治疗学培训计划
- 批准号:
9793609 - 财政年份:2019
- 资助金额:
$ 42.63万 - 项目类别:
Vascular Biology, Signaling and Therapeutics training program
血管生物学、信号传导和治疗学培训计划
- 批准号:
10186473 - 财政年份:2019
- 资助金额:
$ 42.63万 - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
$ 42.63万 - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
$ 42.63万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
$ 42.63万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
$ 42.63万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
$ 42.63万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
$ 42.63万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
$ 42.63万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
$ 42.63万 - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
$ 42.63万 - 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
- 批准号:
2702283 - 财政年份:1997
- 资助金额:
$ 42.63万 - 项目类别: